See what questions
a doctor would ask.
Pharmixis Ltd is seeking approval from the Therapeutic Goods Administration to sell its drug Aridol in Australia. Aridol is aimed at diagnosing asthma patients and managing the condition. It is a dry powder which requires an inhaler to deliver it to the lungs. The results can show how severe the asthma is and how beneficial the medication being used is. It can also be used to determine if inhaled steroids will benefit chronic obstructive pulmonary disease sufferers. Aridol treatment can be done in a GP's office. Clinical trials involving the drug showed a good correlation between a physician's diagnosis and diagnosis through Aridol. Aridol also suggested that 25% of asthmatics tested needed some change to her medication with about 17% being able to reduce their level of medication without harm.
Source: summary of medical news story as reported by PharmaLive
About: Asthma diagnosis by using Aridol awaiting approval in Australia
Date: 18 January 2005
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City